GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Glucose Health, Inc.

Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017

$0.44+0.10 (+28.76%)

Close on Oct 19, 2026

Community

Notes and questions about Glucose Health from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Glucose Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-50 reverse split on Mar 30, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GLUC.

Revenue growth-70.6% · median -11.3%

Gross margin65.4% · median 61.1%

Operating margin-36.8% · median -18.6%

Net margin-96.5% · median -14.0%

Advertisement
300 × 250